avb6 integrin inhibitor + lysosomal degrader in vitro degradation, Ph. I completed, discont. derived from prior integrin inhibitors J. Pharmacol. Exp. Ther., Jan. 26, 2021 GlaxoSmithKline, Stevenage, UK